SynthesisHerz2016

[Cardiovascular risk of androgen deprivation therapy for treatment of hormone-dependent prostate cancer : Differences between GnRH antagonists and GnRH agonists].

C Tschöpe et al.PubMed ↗Publisher ↗

No numbers read from the abstract.